# TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia

> **NCT03136445** · PHASE3 · COMPLETED · sponsor: **NHS Blood and Transplant** · enrollment: 616 (actual)

## Conditions studied

- Hematologic Neoplasms
- Hemorrhage
- Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Tranexamic acid (TXA).
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03136445
- **Lead sponsor:** NHS Blood and Transplant
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2022-02-18
- **Final completion:** 2022-06-18
- **Target enrollment:** 616 (ACTUAL)
- **Last updated:** 2025-10-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03136445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03136445, "TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03136445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*